Research Highlights Expanded Clinical Uses of SGLT2 Inhibitors Medha Baranwal6 Jan 2025 8:30 AM ISTUSA: A recent editorial published in the Journal of Cardiothoracic and Vascular Anesthesia highlights the growing clinical applications of...
Canagliflozin Enhances Iron Utilization and Hemoglobin Levels in Diabetic CKD Patients, CREDENCE Trial Reveals Dr Kartikeya Kohli13 Nov 2024 9:30 AM ISTAustralia: Recent findings from the CREDENCE trial have shed light on the significant role of Canagliflozin, a sodium-glucose co-transporter 2 (SGLT2)...
SGLT2 inhibitor canagliflozin has Heart and kidney benefits among patients across all age categories: Study Dr Kartikeya Kohli28 Oct 2024 8:30 PM ISTSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is...
Canagliflozin Effective in Slowing Kidney Function Decline in Early-Stage CKD, reveals research Dr Kartikeya Kohli12 Sept 2024 4:30 AM ISTA recent study published in the Kidney International found that the sodium-glucose cotransporter 2 (SGLT2) inhibitor canagliflozin may significantly...
Canagliflozin improves diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns: Study Medha Baranwal22 Feb 2024 6:00 AM ISTChina: Canagliflozin (CANA) regulates metabolic reprogramming in diabetic kidney disease (DKD) by inducing fasting-like and aestivation-like metabolic...
Earlier treatment with SGLT2 inhibitor canagliflozin confers cardiorenal benefits in type 2 diabetes Medha Baranwal7 Feb 2024 10:00 AM ISTCanada: A pooled analysis of the CANVAS Program and CREDENCE trials showed that earlier treatment with canagliflozin confers consistent cardiorenal...
Lupin gets tentative USFDA nod for Canagliflozin, Metformin Hydrochloride ER tablets Ruchika Sharma8 Nov 2023 10:52 AM ISTCanagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in...
Simple blood test may predict risk of future heart, kidney disease in type 2 diabetes patients Dr. Kamal Kant Kohli22 Aug 2023 8:00 PM ISTUSA: A simple blood test was shown to predict the risk of progressive kidney and heart disease in patients with type 2 diabetes and kidney disease in...
Medical Bulletin 22/August/2023 Isra Zaman22 Aug 2023 3:15 PM ISTHere are the top medical news of the day:Prostate cancer drug potential against COVIDAt the outset of the COVID pandemic, men appeared to suffer...
Blood test may predict future heart, kidney risk for Type 2 diabetics Isra Zaman22 Aug 2023 9:30 AM ISTA simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease, according to new...
Canagliflozin may help treat autoimmune disorders like RA and SLE Dr. Kamal Kant Kohli30 May 2023 11:00 AM ISTSwansea University researchers have found that a drug commonly used to treat type 2 diabetes can potentially be used in the treatment of autoimmune...
Canagliflozin consistently effective for patients of different age groups with diabetic kidney disease Dr Kartikeya Kohli21 March 2023 9:15 AM ISTAustralia: Canagliflozin consistently reduced adverse kidney and cardiovascular events in patients with diabetic kidney disease independent of sex or...
